How to improve outcomes of your viral vectors for gene therapy with high-quality data from biophysical profiling methods

November 4, 2021

Optimizing your vectors for gene therapy is a daunting task. When developing and optimizing AAVs, concerns such as serotype, storage stability, expression method, and genetic fill level must be addressed before a therapeutic vector reaches clinical application. With biophysical characterization tools, it is possible to address these questions and determine the best formulation for your AAV development needs. The proper tool will give you the high-quality data you require, without using lots of precious sample. Watch this video to learn how NanoTemper is addressing the needs of gene therapy researchers.

Previous Video
DLS easily explained: What it tells you about your protein
DLS easily explained: What it tells you about your protein

Join this webinar to learn about the physical phenomenon that drives Dynamic Light Scattering (DLS), and se...

Up next
Stepwise conformational stabilization of a HIV-1 clade C consensus envelope trimer immunogen impacts vaccine-induced antibody responses
Stepwise conformational stabilization of a HIV-1 clade C consensus envelope trimer immunogen impacts vaccine-induced antibody responses

Ready to tackle your challenging stability characterizations?

Discover tools